DIAGNOS Inc. announced a non brokered private placement to issue 4,285,714 units, issued at a price of CAD 0.28 per Unit for the gross proceeds of CAD 1,192,439.92 on February 27, 2024. Each Unit consists of One common share and One common share warrant. Each Warrant can be exercised to purchase one Share at a price of CAD 0.40 per Share for a period of 18 months.

On the same date, the company announced that it has issued 1,414,286 units issued at a price of CAD 0.28 per Unit, for gross proceeds of CAD 396,000.08 in the first tranche. Each Unit consists of One common share and One common share warrant. Each Warrant can be exercised to purchase one Share at a price of CAD 0.40 per Share for a period of 18 months ending August 27, 2025. An aggregate number of 1,414,286 Warrants have been issued as part of the closing of the first tranche of the Private Placement. In connection with the closing of the first tranche of the Private Placement, the Corporation shall pay a cash commission of CAD 13,720 to one qualified firm acting at arm?s length and issue 49,000 finder?s warrants to the Finder. Each finder?s warrant entitles the Finder to purchase one Share at an exercise price of CAD 0.40 per Share for a period of 18 months ending August 27, 2025. All securities issued as part of the first tranche of the Private Placement are subject to a statutory hold period ending June 28, 2024. One insider of the Corporation, Tristram Coffin, participated in the closing of the first tranche of the Private Placement by subscribing for 700,000 Units representing a cash consideration of CAD 196,000. The closing of the Private Placement remains subject to receipt of all required approvals, including the approval of the TSX Venture Exchange, as well as execution of formal documentation. The company expects to close a second and final tranche of the Private Placement on March 12, 2024.